Work

Suppressor of Tumorigenicity 2 as a Biomarker in Pulmonary Arterial Hypertension and its Association with REVEAL Risk Score in Riociguat-Treated Patients in the RESPITE Study

Year: 2019

Type: article

Source: The Journal of Heart and Lung Transplantation

DOI: 10.1016/j.healun.2019.01.224

Authors: R.L. Benza, J.R. Klinger, H.A. Ghofrani, P. Jansa, E. Grünig, D. Vizza, M.M. Hoeper

Institutions: Allegheny General Hospital, Brown University, Rhode Island Hospital, Justus-Liebig-Universität Gießen, German Center for Lung Research, Universities of Giessen and Marburg Lung Center, Charles University, University Hospital Heidelberg, Sapienza University of Rome, Medizinische Hochschule Hannover

Language: English

Topic: Pulmonary Hypertension Research and Treatments

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2920819335

FWCI:

Cites:

Cited by:

Related to: 10